 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
What's New at The BodyHIV/AIDS News You Can UseNovember 20, 2002 | ||||||||||
HIV Treatment Review From Glasgow Conference"Perhaps most important was the understanding that physicians must now concentrate not only on the power of specific drugs, but on drugs that will improve the quality of patients' lives." Read this terrific overview of HIV treatment in 2002 from Dr. Simon D. Portsmouth. He's one of five HIV experts providing The Body with its coverage of the 6th International Congress on Drug Therapy in HIV Infection, now in progress in Glasgow.More coverage of this conference will roll in through Thanksgiving -- be sure to bookmark this page for the latest highlights! Send an E-Card for World AIDS Day!As part of World AIDS Day 2002 at The Body, we're proud to present this collection of inspired E-cards from Art Action AIDS and Visual AIDS. Do your part to help fight stigma and increase awareness of HIV/AIDS: Send someone you know an E-card!Safe, Savory Eating This Turkey SeasonThanksgiving is one of the most popular holidays in the United States. Nutrition consultant Rosa J. Donohue provides food safety tips and recipes.Keeping Your Bones in ShapeCheck out this easy-to-read, down-to-earth review of bone problems in people with HIV, including a chart of bone-healthy foods."Global HIV Vaccine" Enters Testing ProcessClinical tests have just begun for an HIV vaccine that researchers hope will be effective against many different types of the virus, making it the first-ever "global" HIV vaccine.Sex and Heartbreak: Love Under the Big Top"And then we sent for a clown. A stripper clown, to be exact. ... The music starts and the clown strips down to a pink g-string. Wow, those ain't potatoes. All is going according to plan until I catch the clown and the new love of my life honking each other's horns in the dining room." In Jim Pickett's ever-amusing column, he writes that although love sometimes stinks, he loves it anyway.T-20 Could Make Current Regimens Even BetterA recent clinical study showed that T-20 (enfuvirtide, Fuzeon), a new type of anti-HIV medication nearing government approval, could make people's current drug regimens even more effective. Researchers found that T-20 dramatically reduced people's HIV levels when they were already on a successful two-drug regimen.News for HIV-Positive ArtistsThe latest Visual AIDS newsletter is now available. It's chock-full of opportunities for HIV-positive artists, and includes a listing of upcoming exhibits.HIV Treatment Education: Don't Belittle Your Audience"Sadly, many organizations increasingly infantilize [HIV-]positive clients, treating them like dangerous children who need protection from medical information that could be upsetting or confusing." James Learned, Director of Treatment Education and Editor of ACRIA Update, talks about what it takes to be a great HIV-treatment educator.Whatever May Come, We're Never AloneWhen I wanted to stand,I didn't have to try. Phantom arms gently held me up and I knew no one could love me more. Click here to read the rest of "My Brothers (The Gonzaga Group)," written by an anonymous poet. New Clinical Trials Now EnrollingThe University of Washington has opened a unique new clinical trial aimed at HIVers who have never taken anti-HIV medications. For more information, click here.Visit our newly revamped Clinical Trials section for more info on currently enrolling trials in the U.S. and throughout the world! Who Should Be Vaccinated for Hepatitis A/B?Read the latest recommendations for hepatitis A and B vaccination, provided by the U.S. National Institutes of Health.Finding a Path After Prison"Now that I am out I find it kind of difficult to adjust. What I mean by this is that it's not all flowers and candy." Recently out of prison, HIV-positive Kevin Lisboa now has concrete plans and goals.HAART Prevents Other Illnesses, Study ConfirmsYet another study on how HAART negates the need for special prevention against AIDS-related illnesses: Researchers in Europe say that people on HAART whose CD4 counts were above 200 for at least six months are very unlikely to have a relapse of an opportunistic infection.Disability Insurance in CaliforniaHow can you apply for disability insurance or supplemental income in California? This article from AIDS Project Los Angeles will guide you through the process.Web HighlightsA Selection of the Top HIV/AIDS Stories From Across the Internet:HIV Superinfection and Immune Control: Implications for Vaccine Development? AIDS Leaders Meet Top Bush Officials Medecins Sans Frontieres Criticizes Drug Maker Roche for Failing to Adhere to Pledge to Cut AIDS Drug Prices in Developing Nations IAS-USA Recommendations for the Management of Metabolic Complications (PDF) | ||||||||||
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
